|
RAP2C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.902200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.020490E-02 |
| Normal-vs-Stage2 |
3.698600E-01 |
| Normal-vs-Stage3 |
3.404000E-01 |
| Normal-vs-Stage4 |
6.145000E-01 |
| Stage1-vs-Stage2 |
2.856000E-01 |
| Stage1-vs-Stage3 |
1.023410E-01 |
| Stage1-vs-Stage4 |
6.959800E-02 |
| Stage2-vs-Stage3 |
9.657800E-01 |
| Stage2-vs-Stage4 |
6.920400E-01 |
| Stage3-vs-Stage4 |
6.880800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.627700E-02 |
| Normal-vs-AfricanAmerican |
2.360200E-01 |
| Normal-vs-Asian |
7.019600E-02 |
| Caucasian-vs-AfricanAmerican |
9.459000E-01 |
| Caucasian-vs-Asian |
7.221200E-01 |
| AfricanAmerican-vs-Asian |
7.494800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.034570E-01 |
| Normal-vs-Female |
4.328200E-02 |
| Male-vs-Female |
9.065600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.181100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.333200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.530000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.296400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.315500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.513600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.155000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.103400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.623800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.146800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.444200E-01 |
| Classical-VS-Follicular |
1.875990E-01 |
| Classical-VS-Other |
5.156000E-01 |
| Classical-VS-Normal |
1.176420E-02 |
| Tall-VS-Follicular |
4.533400E-01 |
| Tall-VS-Other |
6.472800E-01 |
| Tall-VS-Normal |
1.407360E-01 |
| Follicular-VS-Other |
9.860200E-01 |
| Follicular-VS-Normal |
5.179600E-01 |
| Other-VS-Normal |
6.729000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.062200E-01 |
| Normal-vs-N1 |
2.608000E-01 |
| N0-vs-N1 |
6.251200E-01 |
|
|
